The FDA’s Ophthalmic Devices Panel will convene tomorrow to discuss potential approval for Second Sight Medical Products’ Argus II retinal prosthesis for the blind.
The "bionic eye," which uses a head-worn camera to capture a scene and process it into electrical signals that are then sent to the cells in the eye, may pose long-term risk that increase over time, according to panel documents released ahead of the meeting.